3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
45
Recurrence
9
Sarcoma, Kaposi
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
Plasmacytoma
1
Plasmablastic Lymphoma
1
Multi-centric Castleman's Disease
1
Malignant Plasma Cell Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Epstein-Barr Virus Infections
1
Interventions
Cyclophosphamide
16
fludarabine
9
Cytarabine
9
venetoclax
8
Mycophenolic Acid
8
Busulfan
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Tacrolimus
5
Daunorubicin
5
Cyclosporine
5
ruxolitinib
4
ponatinib
4
Rituximab
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
Etoposide
4
blinatumomab
3
asciminib
3
Vincristine
3
Prednisone
3
Mercaptopurine
3
Inotuzumab Ozogamicin
3
Dexamethasone
3
Azacitidine
3
revumenib
2
quizartinib
2
pegfilgrastim
2
nilotinib
2
ibrutinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
pomalidomide
×
90 days
×
Clear all
No trials found.